Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens

Journal of Clinical Pathology

Volumn 63, Issue 3, 2010, Pages 235-239

  Lee, Sin Hang ^a   Vigliotti, Veronica S ^a   Pappu, Suri ^a  

^a Milford Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEINASE K; VIRUS DNA;

ADULT; AGED; ARTICLE; DNA FLANKING REGION; DNA SEQUENCE; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS DETECTION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS ISOLATION;

ADULT; AGED; BASE SEQUENCE; DATABASES, NUCLEIC ACID; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; UTERINE CERVICAL NEOPLASMS;

EID: 77749301486     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.069401     Document Type: Article

References (30)

1. Wallin KL, Wiklund F, Angström T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
2. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572-6.
3. Cuschieri KS, Cubie HA, Whitley MW, et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005;58:946-50.
4. Brummer O, Hollwitz B, Bohmer G, et al. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol Oncol 2006;102:517-22.
5. Seabrook JM, Hubbard RA. Achieving quality reproducible results and maintaining compliance in molecular diagnostic testing of human papillomavirus. Arch Pathol Lab Med 2003;127:978-83.
6. Fischer AH. College of American PathologistsdPractice patterns in HPV testing. CAP Today 2008.
7. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
8. Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-57.
9. Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 2008;80:1264-74.
10. van Doorn LJ, Quint W, Kleter B, et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 2002;40:979-83.
11. Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000;38:651-5.
12. Feoli-Fonseca JC, Oligny LL, Brochu P, et al. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol 2001;63:284-92.
13. Kosel S, Burggraf S, Mommsen J, et al. Type-specific detection of human papillomaviruses in a routine laboratory settingeimproved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Clin Chem Lab Med 2003;41:787-91.
14. Johnson T, Bryder K, Corbet S, et al. Routine genotyping of human papillomavirus samples in Denmark. APMIS 2003;111:398-404.
15. Speich N, Schmitt C, Bollmann, et al. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 2004;53:125-8.
16. Asato T, Maehama T, Nagai Y, et al. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 2004;189:1829-32.
17. Lee SH, Vigliotti VS, Vigliotti JS, et al. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agent Cancer 2007;2:11.
18. Lee SH, Vigliotti VS, Pappu S. Human papillomavirus (HPV) infection among women in a representative rural and suburban population of the United States. Int J Gynaecol Obstet 2009;105:210-14.
19. Lee SH, Vigliotti VS, Pappu S. Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen. BMC Womens Health 2009;9:8.
20. Lee SH, Vigliotti VS, Pappu S. DNA sequencing validation of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid tests. Am J Clin Pathol 2008;129:852-9.
21. Lee SH, Vigliotti VS, Vigliotti JS, et al. Validation of human papillomavirus genotyping by signature DNA sequence analysis. BMC Clin Pathol 2009;9:3.
22. Hovey D. State must do more to prevent cervical cancer. http://www.housegop.ct. gov/%5Cpressrel%5CHoveyD112%5C2007%5C20070116-HoveyD112- 01.pdf (accessed 8 December 2009).
23. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006;4:221-33.
24. Rodríguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008;100:513-17.
25. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004;324:17-27.
26. Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995;69:3074-83.
27. Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
28. Vernon SD, Farkas DH, Unger ER, et al. Bioelectronic DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogens. BMC Infect Dis 2003;3:12.
29. Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, et al. Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med 2008;168:1881-9.
30. Naucler P, Ryd W, Törnberg S, et al. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst 2009;101:88-99.